Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yajing Yang

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Frontiers in Nutrition|August 4, 2022
Sarcopenia Was a Poor Prognostic Predictor for Patients With Advanced Lung Cancer Treated With Immune Checkpoint InhibitorsShuluan Li, Zhou Liu, Ya Ren, et al.
Complementary Therapies in Medicine|March 8, 2024
Current state of research on exercise for the treatment of myasthenia gravis: A scoping reviewSiyang Peng, Linghao Meng, Ruiying Fang, et al.
Frontiers in Neurology|January 12, 2024
Mapping current trends and hotspots in myasthenia gravis from 2003 to 2022: a bibliometric analysisYukun Tian, Qiqi Shen, Siyang Peng, et al.
Molecular Cancer Therapeutics|March 17, 2026
Balancing the Dual Mechanisms of Anti-VISTA mAbs for Anti-Tumor Activity: CD8+ T Cell Responses and Fc-dependent Depletion of VISTA-Expressing Immune CellsMiaomiao He, Tianqi Cao, Kailun Wang, et al.
Frontiers in Oncology|August 14, 2023
Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinomaChristopher Kwok, Adam Khorasanchi, Sarah P Psutka, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2022
D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1Ruonan Zhang, Yajing Yang, Wenjing Dong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2024
A CD25×TIGIT bispecific antibody induces anti-tumor activity through selective intratumoral Treg cell depletionXin Wei, Linlin Zhao, Fang Yang, et al.
Iscience|May 11, 2026
The choroidal macrophage polarization significantly influences myopia development in murine modelsJing Hou, Shin-Ichi Ikeda, Yajing Yang, et al.
Inorganic Chemistry|January 22, 2020
An Application Exploiting Aurophilic Bonding and iClick to Produce White Light Emitting MaterialsChristopher C Beto, Charles J Zeman, Yajing Yang, et al.
Cancer Research|August 15, 2008
Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivoYihong Zhang, Paula J Kaplan-Lefko, Karen Rex, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Frontiers in Nutrition|August 4, 2022
Sarcopenia Was a Poor Prognostic Predictor for Patients With Advanced Lung Cancer Treated With Immune Checkpoint InhibitorsShuluan Li, Zhou Liu, Ya Ren, et al.
Complementary Therapies in Medicine|March 8, 2024
Current state of research on exercise for the treatment of myasthenia gravis: A scoping reviewSiyang Peng, Linghao Meng, Ruiying Fang, et al.
Frontiers in Neurology|January 12, 2024
Mapping current trends and hotspots in myasthenia gravis from 2003 to 2022: a bibliometric analysisYukun Tian, Qiqi Shen, Siyang Peng, et al.
Molecular Cancer Therapeutics|March 17, 2026
Balancing the Dual Mechanisms of Anti-VISTA mAbs for Anti-Tumor Activity: CD8+ T Cell Responses and Fc-dependent Depletion of VISTA-Expressing Immune CellsMiaomiao He, Tianqi Cao, Kailun Wang, et al.
Frontiers in Oncology|August 14, 2023
Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinomaChristopher Kwok, Adam Khorasanchi, Sarah P Psutka, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2022
D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1Ruonan Zhang, Yajing Yang, Wenjing Dong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2024
A CD25×TIGIT bispecific antibody induces anti-tumor activity through selective intratumoral Treg cell depletionXin Wei, Linlin Zhao, Fang Yang, et al.
Iscience|May 11, 2026
The choroidal macrophage polarization significantly influences myopia development in murine modelsJing Hou, Shin-Ichi Ikeda, Yajing Yang, et al.
Inorganic Chemistry|January 22, 2020
An Application Exploiting Aurophilic Bonding and iClick to Produce White Light Emitting MaterialsChristopher C Beto, Charles J Zeman, Yajing Yang, et al.
Cancer Research|August 15, 2008
Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivoYihong Zhang, Paula J Kaplan-Lefko, Karen Rex, et al.
Pageof 11